Integrated Nanotherapeutics Inc.

15 records totalling $2,912,575.57 CAD, from official Government of Canada open data.

Embed this chart

Names on this page

The source files have no identifier for a recipient, and departments write the same name in different ways. This page puts together the records with these names. They differ only in letter case, accents, punctuation, "&" and "and", an article at the start, the legal form at the end (Inc., Ltd., LLP), or the French half of a name in two languages. How names are matched

By department

Records

National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2024-2025
Canada

Evaluation of a tolerogenic LNP (lipid nanoparticle) formulation to treat type 1 diabetes in non-obese diabetic (NOD) mice, an established mouse model of type 1 diabetes.

National Research Council Canada
Industrial Research Assistance Program
FY 2025-2026
Canada

Development of INT-101 formulation for human dosing and prevention of diabetes

National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2019-2020
Canada

This project aims to develop effective immunomodulatory formulations to induce immune tolerance as a therapeutic strategy for autoimmune and inflammatory diseases.

National Research Council Canada
Research contracts
FY 2020-2021
Canada

This contract was awarded by Public Works and Government Services Canada. This contract was competitively sourced.

National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2018-2019
Canada

This project aims to develop effective immunomodulatory formulations to induce immune tolerance as a therapeutic strategy for autoimmune and inflammatory diseases.

Western Economic Diversification Canada
Regional Economic Growth through Innovation
FY 2018-2019
Canada

Develop and market novel therapies for the treatment of diabetes

National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2021-2022
Canada

Development of lipid nanoparticles (LNP) encasing mRNA for vaccines.

National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2023-2024
Canada

ICAP 2022 – International Co-Innovation Action Plan

National Research Council Canada
Industrial Research Assistance Program – Youth Employment Program
FY 2020-2021
Canada

Development of immunomodulatory formulations for inflammatory diseases

National Research Council Canada
CanExport
FY 2026-2027
Canada

The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a...

Global Affairs Canada
Canadian International Innovation Program (CIIP)
FY 2022-2023
Canada

The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research...

Global Affairs Canada
CanExport - Innovation
FY 2019-2020
Canada

The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other...